Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2021

View Archived Issues

OPS-2071 shows potent in vitro and in vivo activity against Clostridioides difficile

New Raf kinase C inhibitors identified at Medshine Discovery

Cadila Healthcare discovers NLRP3 inflammasome inhibitors

Kallyope describes new SSTR5 antagonists

New PRMT5 inhibitors discovered at Lupin

First-in-human study finds CEB-01 implant safe in patients with retroperitoneal soft tissue sarcoma

TAT therapy with FPI-1792 plus checkpoint inhibitors eradicates colon cancer tumors in vivo

Second ANAVEX2-73 trial confirms SIGMAR1 mRNA expression as predictive biomarker of response

Topline phase I data presented for DARE-HRT1 for hormonal therapy after menopause

Genetic study unveils loss-of-function variants in BCAS3 causing a neurodevelopmental disorder

RNA helicase DDX3X identified as an attractive target for host-directed therapy against SARS-CoV-2

Ideaya provides clinical updates for IDE-397 phase I study and darovasertib combination trial

First patient dosed in phase I/II study of ANV-419 in solid tumors

Umbilical cord-derived mesenchymal stem cells show clinical efficacy in patients with COVID-19

FDA clears IND application for ORIC-533

Interim data from phase II CORIST study of SCO-101 in metastatic colorectal cancer

LDL receptor overexpression affects tauopathy in Alzheimer's model

Venatorx initiates phase I trial of VNRX-9945 for chronic hepatitis B

Human placenta-derived exosomes for the treatment of ischemia

Q-State reports preclinical proof-of-concept data for QSB-490 in spastic paraplegia type 49

First-in-human data for SCO-267 in healthy adults and subjects with glucose intolerance

SAB Biotherapeutics initiates phase IIa trial of SAB-176 for influenza

DiaMedica reports interim phase II data on DM-199 in chronic kidney disease

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...